
Multi-peptide research blend (GHK-Cu · KPV · BPC-157 · TB-500) supplied for in-vitro research.
KLOW Blend 70 mg is not yet released for sale. Batch release, HPLC certification and third-party testing are in progress — check back shortly.
The KLOW Blend brings together four synthetic research peptides frequently referenced side-by-side in in-vitro laboratory literature: GHK-Cu (copper tripeptide-1), KPV (a lysine–proline–valine tripeptide), BPC-157 (a synthetic pentadecapeptide) and TB-500 (a synthetic thymosin β4 fragment).
Every vial is manufactured to strict laboratory standards, HPLC-characterised per component and independently third-party tested. Pre-blending simplifies procurement for research workflows that routinely combine these four peptides.
The KLOW Blend is referenced in laboratory work involving:
All work described in the scientific literature is conducted in controlled in-vitro laboratory environments.
Every KLOW Blend vial supplied by NXT GEN PEPTIDES is HPLC-characterised per component and independently third-party tested, giving researchers consistent, well-documented material for their laboratory workflow.
Store lyophilised at -20 °C. After reconstitution, store at 2–8 °C and use within 28 days.
This blend is supplied exclusively for scientific and laboratory research. It is not intended for human or veterinary consumption, administration, diagnosis, treatment or therapeutic use.

Triple agonist research peptide (GLP-1/GIP/glucagon).

Larger-format triple agonist research peptide (GLP-1/GIP/glucagon) — 40 mg vial.

Synthetic pentadecapeptide fragment for in-vitro laboratory characterisation.

Synthetic thymosin β4 fragment for in-vitro laboratory characterisation.
This site sells research chemicals for in-vitro laboratory research only. You must be 18+ to enter. A full research-use questionnaire and acknowledgements will be required before you can place an order.
Research use only · Not for human or animal consumption